Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment. - Wikidata - wikimedia - TriplyDB

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.

http://www.wikidata.org/entity/Q37985523

about

Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression Ocular indicators of Alzheimer's: exploring disease in the retina Metal imaging in neurodegenerative diseases.Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to Beta amyloid in the lens of human eye: an exploratory study Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease.Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage.Analysis of Retinal Peripapillary Segmentation in Early Alzheimer's Disease Patients.Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.Melanopsin retinal ganglion cell loss in Alzheimer disease.BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease.Nonvascular retinal imaging markers of preclinical Alzheimer's disease.Amyloid Plaques in Retina for Diagnosis in Alzheimer's Patients: a Meta-Analysis.Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.Visualization of neuritic plaques in Alzheimer's disease by polarization-sensitive optical coherence microscopy.What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders.Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review.Retinal manifestations of Alzheimer's disease.Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience.Clinical development of curcumin in neurodegenerative disease.Oculo-visual changes and clinical considerations affecting older patients with dementia.Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.Visual system manifestations of Alzheimer's disease.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.A review of curcumin as a biological stain and as a self-visualizing pharmaceutical agent.Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration.Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.Design, synthesis and biological evaluation of trimethine cyanine dyes as fluorescent probes for the detection of tau fibrils in Alzheimer's disease brain and olfactory epithelium.Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.Can the retina be used to diagnose and plot the progression of Alzheimer's disease?Impaired retinal microcirculation in patients with Alzheimer's disease.Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin.A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.[(3) H]-L685,458 binding sites are abundant in multiple peripheral organs in rats: implications for safety assessment of putative γ-secretase targeting drugs.

P2860

Q26752621-663F2B96-44F1-489D-A358-8306D71AD137 Q28078670-7222480B-2788-4442-87D4-1EFDBA6379BF Q34073566-07B649AF-4445-4900-8740-5D9ABF1353C0 Q34541965-A58EF026-B931-4014-B22E-B1E4A15E212C Q34743196-4085ED1D-4881-4AB8-955F-F2E8145131E0 Q34761039-A1E46ADD-218E-4099-B0BF-A087CF1C5A8A Q34764050-0F09691B-B6CD-4789-AC98-CDBC2B066523 Q35128118-30C54F77-8433-4B84-9E9D-E826073A8423 Q35708602-ED907757-737E-4D15-B2B8-9A38C1C25A97 Q35845240-2BBFAAC6-C4F6-467B-A01B-2E63F04473A3 Q36236460-F918EC68-9843-4580-8F50-CF02C9FBBEBF Q36532692-3E6C8942-41C2-49A9-B0C0-4EF97A9560D6 Q36533171-554EFAB7-0B0D-4899-BEA5-0CBC23033FE7 Q36790844-B61EF1BB-2E17-469A-B2F5-8252A6471C86 Q37363628-73547334-6696-4FEA-8174-1CF4F1A70A5F Q37405016-D0FDE7BF-391B-4103-855C-8901757BA1FA Q37612356-D3BB8F11-F052-4268-9105-727A35A3F415 Q37679166-85D76123-F51C-4AF4-BB2A-18A01C91F06C Q37681751-CB1D016D-AAA5-4F48-8D2A-A878E4B319A7 Q38038399-AA1C48AB-A364-4650-9CB8-8C4C74868D6C Q38231124-775A91BD-6AE7-4AB5-8BD1-625C27CECEF8 Q38237224-70ECB5CD-BE3F-4EC0-9EC2-2C8A14E8076D Q38333029-EB2F52D5-DBB3-4CF4-ACE1-2DC8F0E1C59E Q38513024-9440D2D8-0748-4056-B746-92AF42A31456 Q38533327-F73D42E5-2906-4270-8A13-0193F4EA9E6A Q38559734-FAA36453-3BFA-44D6-81C8-6CBAF59C076F Q39013852-74DC75D2-CC1F-436D-9490-B25A0015B103 Q39135845-4C0AF677-F4CA-4B0D-BB31-96867583D549 Q39307463-91D22956-8E2D-4F15-B752-2EBB741442B2 Q39361638-993772F9-56F2-44B5-8E64-48EB14CB49B9 Q41845723-A4F10A3A-9B44-410A-9F91-6D66BA271AA4 Q42095746-C02A2CD5-71DC-404B-BB1D-9822F711298E Q44143296-16AEEC1E-9B55-4459-AFF3-ED2C13E67A03 Q47125047-2CCBEF32-1EA6-4E46-83E4-0DA92D4E6A3F Q47221811-8B8AFABF-EAC2-4832-BFCC-3ADF98C3DD72 Q47315641-FFF528E1-C5E1-4FBD-BCB6-1D34BBEBC601 Q47549495-BCB51970-1BDD-4EB8-AE3B-513E79ABFE0C Q47845944-D8556EB4-19C5-4E2F-A22F-4F06BC20177F Q48469277-8FA513A6-F8A4-42E6-ACE1-484748E3A775 Q48767057-9D7AA28A-18A2-438F-B807-4B5B035CEC9E

P2860

Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.

http://www.wikidata.org/entity/Q37985523

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@en

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@nl

type

label

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@en

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@nl

prefLabel

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@en

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@nl

P1433

Q37985523-40A6B08D-5A28-46B6-A5FC-2F469A9AC926

P1476

Q37985523-94979390-A429-4E0B-84E3-631E991A9F05

P2093

Q37985523-707554EA-3A86-4ADB-A7B6-AEF8BB524048

Q37985523-777932F1-C1C6-40C3-A0A4-549301A37726

Q37985523-A0A6D448-8DE5-43D2-96FD-EE4FC99A542F

Q37985523-A87AE795-4742-4C9B-920B-951C420C8E9B

P2860

Q37985523-0243C27C-F6AC-42E8-94AB-67C1D3CACA7F

Q37985523-035224D3-68BF-4AA5-905A-70C9939454E1

Q37985523-0455B040-58FE-4761-A4B8-046E985DD0DF

Q37985523-05F9BF11-13C2-463B-B195-69952D8683E6

Q37985523-062990E0-F47E-40AA-9B3E-090C339A9831

Q37985523-06F3BEF2-E7CF-4B21-8290-ECDA1F51AD72

Q37985523-096C2B72-8FA0-4CD8-A08A-C690B673492D

Q37985523-09B5F158-EB5D-43F9-A79C-B338069B52A0

Q37985523-0BA50F97-1C8F-4D57-8CC5-0AFF74D65D1D

Q37985523-0EA8ADC0-8F0B-4408-AD44-5EB7CFB8DE12

P304

Q37985523-5BE8DE99-0F34-4D90-9378-F7B29DB57CD2

P31

Q37985523-00019120-72BE-41DA-B03C-E8A323C01755

P356

Q37985523-9E4BF05B-6A52-4139-B6B1-8526AA5F5B18

P433

Q37985523-50614BE4-EE4B-4536-971A-31317D434EDB

P478

Q37985523-D49C83E3-7D83-4A31-A326-22C831A9727B

P577

Q37985523-5EB453A7-FA67-4720-AF00-CE22FE2E2191

P5875

Q37985523-6A98613F-9DBD-45BA-A6A1-470832169478

P698

Q37985523-7F4E4334-44E6-448B-9DEE-22724A4A176D

P921

Q37985523-2e23bd89-4f63-4613-a0d1-5fc7baaf2b5a

Q37985523-CAAF8FEF-4DA2-4D16-A05E-E4293DC32E43

P356

P1433

Neurodegenerative Diseases

P1476

Alzheimer's disease in the ret ...... gnosis and therapy assessment.

@en

P2093

Brenda C Salumbides

http://www.w3.org/2001/XMLSchema#string

Keith L Black

http://www.w3.org/2001/XMLSchema#string

Maya Koronyo-Hamaoui

http://www.w3.org/2001/XMLSchema#string

Yosef Koronyo

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

Targeting amyloid-beta in glaucoma treatment.

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Bioavailability of curcumin: problems and promises

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

P304

285-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000335154

http://www.w3.org/2001/XMLSchema#string

P433

1-4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221841266

http://www.w3.org/2001/XMLSchema#string

P698

22343730

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease